Healthcare Providers
For Patients
About Us
Who We Are
Our Team
Board of Directors
Corporate Giving
Our Science
Science of C3
Our Pipeline
Clinical Trials
Focus Areas
Ophthalmology
Rare Disease
Research
Our Product
Careers
Our Culture
Benefits
Open Positions
Investors & Media
Overview
Stock Information
News Releases
Perspectives
Events & Presentations
Corporate Governance
Financials & Filings
Investor FAQs
Investor Resources
Home
About Us
Who We Are
Our Team
Board of Directors
Corporate Giving
Our Science
Science of C3
Our Pipeline
Clinical Trials
Focus Areas
Ophthalmology
Rare Disease
Research
Our Product
Careers
Our Culture
Benefits
Open Positions
Investors & Media
Overview
Stock Information
News Releases
Perspectives
Events & Presentations
Corporate Governance
Financials & Filings
Investor FAQs
Investor Resources
Healthcare Providers
For Patients
Courageous
Science +
Compassion
Leading the way in complement science for patients
NEWS
Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer
All news
Redefining Treatment
in PNH with the first new class of complement medicine in 15 years »
Fearlessly Advancing
the first potential treatment for people with geographic atrophy »
Previous
Next
Our Pipeline
We aim to transform treatment across a
broad range of debilitating diseases driven by complement »
We Replace
Impossible with How
We challenge conventional thinking and always question if there's a better way.
Join the Team